2型糖尿病治療の市場規模、シェア、動向分析レポート：薬剤クラス別、投与経路別、流通チャネル別、地域別、セグメント予測、2024年～2030年

2型糖尿病治療市場の成長と動向：

Grand View Research, Inc.の調査レポートによると、世界の2型糖尿病治療の市場規模は2030年までに919億米ドルに達し、2024年から2030年までのCAGRは6.9%で成長すると予測されています。

この拡大は、2型糖尿病の世界の負担増と治療オプションの進歩によってもたらされます。食生活の乱れや運動不足といったライフスタイルの変化が肥満率の上昇につながる中、2型糖尿病の罹患率は上昇傾向にあります。国際糖尿病連合（IDF）によると、世界中で5億人以上が糖尿病に罹患しており、その約90％を2型糖尿病が占めています。このような患者数の増加は、効果的で革新的な治療に対する需要を煽っています。

糖尿病管理の進歩が市場の成長を後押ししています。GLP-1受容体作動薬やSGLT2阻害薬といった新しいクラスの治療薬が開発されたことで、治療成績が大幅に向上しました。これらの治療薬は血糖値を下げるだけでなく、心血管保護や体重管理といったその他の特典も提供します。持続血糖モニターやインスリンポンプなど、新しいインスリン製剤や技術のイントロダクションは、患者ケアをさらに向上させ、市場拡大の原動力となっています。例えば、2023年1月、食品医薬品局（FDA）は、ノボ・ノルディスクの糖尿病治療薬「リベルサス」を血糖値を下げる第一選択薬として承認しました。この承認により、2型糖尿病患者はヘルスケアプロバイダーと協力して、治療計画の早い段階からリベルサスを取り入れることができるようになり、発症時から病状を管理するための新たな選択肢を提供できるようになった。

加えて、ヘルスケア投資の増加と糖尿病治療へのアクセスの向上も市場の成長に寄与しています。各国政府や医療機関は、糖尿病管理プログラム、国民の意識向上キャンペーン、ヘルスケア・インフラの整備に投資しています。これらの取り組みは、早期診断、治療アドヒアランス、全体的な患者管理を強化することを目的としています。

2型糖尿病治療市場レポート・ハイライト

• 2023年、2型糖尿病治療市場ではインスリン製剤が32.8%の最大売上シェアを占めました。この成長は主に、座りがちなライフスタイルにより世界中で2型糖尿病の有病率が上昇していることに起因しています。
• 予測期間中、2型糖尿病治療市場で最も高いCAGR（9.4％）を達成すると予測されているのは皮下注射です。
• 小売薬局セグメントは、2023年の2型糖尿病治療市場において約70.0%の最大の売上シェアを占めました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 2型糖尿病治療市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• 2型糖尿病治療市場、市場分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析

第4章 2型糖尿病治療市場：薬剤クラス別推定・動向分析

• 世界の2型糖尿病治療市場：薬剤クラスダッシュボード
• 世界の2型糖尿病治療市場：薬剤クラスの変動分析
• 世界の2型糖尿病治療市場：薬剤クラス別収益
• インスリン
• DPP-4阻害剤
• GLP-1受容体作動薬
• SGLT2阻害剤
• その他

第5章 2型糖尿病治療市場：投与経路別推定・動向分析

• 世界の2型糖尿病治療市場：投与経路ダッシュボード
• 世界の2型糖尿病治療市場：投与経路の変動分析
• 投与経路別収益
• 経口
• 皮下
• 静脈内

第6章 2型糖尿病治療市場：流通チャネル別推定・動向分析

• 世界の2型糖尿病治療市場：流通チャネルダッシュボード
• 世界の2型糖尿病治療市場：流通チャネル変動分析
• 流通チャネル別収益
• 小売薬局
• 病院薬局
• その他

第7章 2型糖尿病治療市場：薬剤クラス別、投与経路、流通チャネル別の地域別推定・動向分析

• 地域ダッシュボード
• 市場規模、予測動向分析、2018年から2030年：
• 北米
• 欧州
• アジア太平洋
• ラテンアメリカ
• 中東・アフリカ

第8章 競合情勢

• 企業/競合の分類
• ベンダー情勢
  • 主要販売代理店およびチャネルパートナーのリスト
  • 主要企業の市場シェア分析、2023年
  • AstraZeneca PLC
  • Boehringer Ingelheim International GmbH
  • Eli Lilly and Co.
  • Merck &Co. Inc
  • Novartis AG
  • Novo Nordisk AS
  • Sanofi SA
  • Takeda Pharmaceutical Co. Ltd

List of Tables

• Table 1 List Of Abbreviation
• Table 2 North America Type 2 Diabetes Mellitus Treatment Market, By Region, 2018 - 2030 (USD Million)
• Table 3 North America Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 4 North America Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 5 North America Type 2 Diabetes Mellitus Treatment Market, Distribution Channel, 2018 - 2030 (USD Million)
• Table 6 U.S. Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 7 U.S. Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 8 U.S. Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 9 Canada Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 10 Canada Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 11 Canada Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 12 Mexico Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 13 Mexico Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 14 Mexico Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 15 Europe Type 2 Diabetes Mellitus Treatment Market, By Region, 2018 - 2030 (USD Million)
• Table 16 Europe Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 17 Europe Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 18 Europe Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 19 Germany Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 20 Germany Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 21 Germany Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 22 UK Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 23 UK Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 24 UK Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 25 France Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 26 France Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 27 France Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 28 Italy Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 29 Italy Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 30 Italy Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 31 Spain Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 32 Spain Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 33 Spain Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 34 Denmark Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 35 Denmark Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 36 Denmark Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 37 Sweden Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 38 Sweden Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 39 Sweden Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 40 Norway Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 41 Norway Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 42 Norway Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 43 Asia Pacific Type 2 Diabetes Mellitus Treatment Market, By Region, 2018 - 2030 (USD Million)
• Table 44 Asia Pacific Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 45 Asia Pacific Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 46 Asia Pacific Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 47 China Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 48 China Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 49 China Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 50 Japan Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 51 Japan Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 52 Japan Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 53 India Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 54 India Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 55 India Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 56 South Korea Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 57 South Korea Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 58 South Korea Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 59 Australia Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 60 Australia Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 61 Australia Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 62 Thailand Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 63 Thailand Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 64 Thailand Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 65 Latin America Type 2 Diabetes Mellitus Treatment Market, By Region, 2018 - 2030 (USD Million)
• Table 66 Latin America Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 67 Latin America Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 68 Latin America Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 69 Brazil Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 70 Brazil Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 71 Brazil Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 72 Argentina Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 73 Argentina Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 74 Argentina Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 75 MEA Type 2 Diabetes Mellitus Treatment Market, By Region, 2018 - 2030 (USD Million)
• Table 76 MEA Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 77 MEA Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 78 MEA Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 79 South Africa Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 80 South Africa Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 81 South Africa Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 82 Saudi Arabia Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 83 Saudi Arabia Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 84 Saudi Arabia Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 85 UAE Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 86 UAE Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 87 UAE Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 88 Kuwait Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 89 Kuwait Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 90 Kuwait Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Primary interviews in North America
• Fig. 5 Primary interviews in Europe
• Fig. 6 Primary interviews in APAC
• Fig. 7 Primary interviews in Latin America
• Fig. 8 Primary interviews in MEA
• Fig. 9 Market research approaches
• Fig. 10 Value-chain-based sizing & forecasting
• Fig. 11 QFD modeling for market share assessment
• Fig. 12 Market formulation & validation
• Fig. 13 Type 2 Diabetes Mellitus Treatment Market, Market: Market Outlook
• Fig. 14 Type 2 Diabetes Mellitus Treatment Market, Competitive Insights
• Fig. 15 Parent market outlook
• Fig. 16 Related/ancillary market outlook
• Fig. 17 Type 2 diabetes mellitus treatment Market Driver Impact
• Fig. 18 Type 2 Diabetes Mellitus Treatment Market Restraint Impact
• Fig. 19 Type 2 Diabetes Mellitus Treatment Market Strategic Initiatives Analysis
• Fig. 20 Type 2 Diabetes Mellitus Treatment Market: Drug Class Movement Analysis
• Fig. 21 Type 2 Diabetes Mellitus Treatment Market: Drug Class Outlook And Key Takeaways
• Fig. 22 Insulin market estimates and forecast, 2018 - 2030
• Fig. 23 DPP-4 inhibitors market estimates and forecast, 2018 - 2030
• Fig. 24 GLP-1 receptor agonists market estimates and forecast, 2018 - 2030
• Fig. 25 SGLT2 inhibitors market estimates and forecast, 2018 - 2030
• Fig. 26 Other market estimates and forecast, 2018 - 2030
• Fig. 27 Type 2 Diabetes Mellitus Treatment Market: Route of Administration Movement Analysis
• Fig. 28 Type 2 Diabetes Mellitus Treatment Market: Route of Administration Outlook And Key Takeaways
• Fig. 29 Oral market estimates and forecast, 2018 - 2030
• Fig. 30 Subcutaneous market estimates and forecast, 2018 - 2030
• Fig. 31 Intravenous market estimates and forecast, 2018 - 2030
• Fig. 32 Type 2 Diabetes Mellitus Treatment Market: Distribution Channel Movement Analysis
• Fig. 33 Type 2 Diabetes Mellitus Treatment Market: Distribution Channel Outlook And Key Takeaways
• Fig. 34 Retail pharmacies market estimates and forecast, 2018 - 2030
• Fig. 35 Hospital pharmacies market estimates and forecast, 2018 - 2030
• Fig. 36 Other market estimates and forecast, 2018 - 2030
• Fig. 37 Global Type 2 Diabetes Mellitus Treatment Market: Regional Movement Analysis
• Fig. 38 Global Type 2 Diabetes Mellitus Treatment Market: Regional Outlook And Key Takeaways
• Fig. 39 Global Type 2 Diabetes Mellitus Treatment market share and leading players
• Fig. 40 North America, by country
• Fig. 41 North America market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 42 U.S. key country dynamics
• Fig. 43 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 44 Canada key country dynamics
• Fig. 45 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 46 Mexico key country dynamics
• Fig. 47 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 48 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 49 UK key country dynamics
• Fig. 50 UK market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 51 Germany key country dynamics
• Fig. 52 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 53 France key country dynamics
• Fig. 54 France market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 55 Italy key country dynamics
• Fig. 56 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 57 Spain key country dynamics
• Fig. 58 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 59 Denmark key country dynamics
• Fig. 60 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 61 Sweden key country dynamics
• Fig. 62 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 63 Norway key country dynamics
• Fig. 64 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 65 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 66 China key country dynamics
• Fig. 67 China market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 68 Japan key country dynamics
• Fig. 69 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 70 India key country dynamics
• Fig. 71 India market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 72 Thailand key country dynamics
• Fig. 73 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 74 South Korea key country dynamics
• Fig. 75 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 76 Australia key country dynamics
• Fig. 77 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 78 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 79 Brazil key country dynamics
• Fig. 80 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 81 Argentina key country dynamics
• Fig. 82 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 83 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 84 South Africa key country dynamics
• Fig. 85 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 86 Saudi Arabia key country dynamics
• Fig. 87 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 88 UAE key country dynamics
• Fig. 89 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 90 Kuwait key country dynamics
• Fig. 91 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 92 Market share of key market players- Type 2 Diabetes Mellitus Treatment market

Type 2 Diabetes Mellitus Treatment Market Growth & Trends:

The global type 2 diabetes mellitus treatment market size is anticipated to reach USD 91.9 billion by 2030, growing at a CAGR of 6.9% from 2024 to 2030, according to a report by Grand View Research, Inc. This expansion is driven by the increasing global burden of type 2 diabetes and advancements in treatment options. As lifestyle changes, such as poor dietary habits and physical inactivity, contribute to higher obesity rates, the incidence of type 2 diabetes is on the rise. According to the International Diabetes Federation (IDF), over 500 million people worldwide are affected by diabetes, with Type 2 diabetes accounting for approximately 90% of these cases. This growing patient population fuels demand for effective and innovative treatments.

Advancements in diabetes management are boosting market growth. The development of new classes of medications, such as GLP-1 receptor agonists and SGLT2 inhibitors, has significantly improved treatment outcomes. These therapies not only lower blood glucose levels but also offer additional benefits like cardiovascular protection and weight management. The introduction of novel insulin formulations and technologies, including continuous glucose monitors and insulin pumps, further enhances patient care and drives market expansion. For instance, in January 2023, the Food and Drug Administration (FDA) approved Novo Nordisk's diabetes medication, Rybelsus, as a first-line treatment for lowering blood sugar levels. With this approval, individuals with Type 2 diabetes, in collaboration with their healthcare providers, can now incorporate Rybelsus early in their treatment plan, offering a new option for managing their condition from the onset.

In addition, increasing healthcare investments and improved access to diabetes care contribute to market growth. Governments and healthcare organizations are investing in diabetes management programs, public awareness campaigns, and healthcare infrastructure improvements. These efforts aim to enhance early diagnosis, treatment adherence, and overall patient management.

Type 2 Diabetes Mellitus Treatment Market Report Highlights:

• In 2023, the insulin segment accounted for the largest revenue share of 32.8% in diabetes mellitus, type 2 treatment market. This growth primarily is attributed to the rising prevalence of type 2 diabetes around the world due to sedentary lifestyle
• Subcutaneous are anticipated to achieve the highest CAGR of 9.4% in the diabetes mellitus, type 2 treatment market during the forecast period
• The retail pharmacies segment accounted for the largest revenue share of around 70.0% in diabetes mellitus, type 2 treatment market in 2023

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Drug Class
  • 1.2.2. Route of Administration
  • 1.2.3. Distribution Channel
  • 1.2.4. Regional scope
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Drug Class Outlook
  • 2.2.2. Route of Administration
  • 2.2.3. Distribution Channel
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Type 2 Diabetes Mellitus Treatment Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Rising Prevalence of Diabetes
    • 3.2.1.2. Advancements In Treatment Options
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. High Treatment Cost
    • 3.2.2.2. Patient Non-Adherence
• 3.3. Type 2 Diabetes Mellitus Treatment Market, Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. Type 2 Diabetes Mellitus Treatment Market: Drug Class Estimates & Trend Analysis

• 4.1. Global Type 2 Diabetes Mellitus Treatment Market: Drug Class Dashboard
• 4.2. Global Type 2 Diabetes Mellitus Treatment Market: Drug Class Movement Analysis
• 4.3. Global Type 2 Diabetes Mellitus Treatment Market by Drug Class, Revenue
• 4.4. Insulin
  • 4.4.1. Insulin market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. DPP-4 Inhibitors
  • 4.5.1. DPP-4 Inhibitors market estimates and forecasts 2018 to 2030 (USD Million)
• 4.6. GLP-1 Receptor Agonists
  • 4.6.1. GLP-1 Receptor Agonists market estimates and forecasts 2018 to 2030 (USD Million)
• 4.7. SGLT2 Inhibitors
  • 4.7.1. SGLT2 Inhibitors market estimates and forecasts 2018 to 2030 (USD Million)
• 4.8. Others
  • 4.8.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Type 2 Diabetes Mellitus Treatment Market: Route of Administration Estimates & Trend Analysis

• 5.1. Global Type 2 Diabetes Mellitus Treatment Market: Route of Administration Dashboard
• 5.2. Global Type 2 Diabetes Mellitus Treatment Market: Route of Administration Movement Analysis
• 5.3. Global Type 2 Diabetes Mellitus Treatment Market Estimates and Forecasts, By Route of Administration, Revenue (USD Million)
• 5.4. Oral
  • 5.4.1. Oral market estimates and forecasts 2018 to 2030 (USD Million)
• 5.5. Subcutaneous
  • 5.5.1. Subcutaneous market estimates and forecasts 2018 to 2030 (USD Million)
• 5.6. Intravenous
  • 5.6.1. Intravenous market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Type 2 Diabetes Mellitus Treatment Market: Distribution Channel Estimates & Trend Analysis

• 6.1. Global Type 2 Diabetes Mellitus Treatment Market: Distribution Channel Dashboard
• 6.2. Global Type 2 Diabetes Mellitus Treatment Market: Distribution Channel Movement Analysis
• 6.3. Global Type 2 Diabetes Mellitus Treatment Market Estimates and Forecasts, By Distribution Channel, Revenue (USD Million)
• 6.4. Retail Pharmacies
  • 6.4.1. Retail Pharmacies market estimates and forecasts 2018 to 2030 (USD Million)
• 6.5. Hospital Pharmacies
  • 6.5.1. Hospital Pharmacies market estimates and forecasts 2018 to 2030 (USD Million)
• 6.6. Other
  • 6.6.1. Other market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Type 2 Diabetes Mellitus Treatment Market: Regional Estimates & Trend Analysis by Drug Class, Route of Administration, and Distribution Channel

• 7.1. Regional Dashboard
• 7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 7.3. North America
  • 7.3.1. U.S.
    • 7.3.1.1. Key country dynamics
    • 7.3.1.2. Regulatory framework/ reimbursement structure
    • 7.3.1.3. Competitive scenario
    • 7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.3.2. Canada
    • 7.3.2.1. Key country dynamics
    • 7.3.2.2. Regulatory framework/ reimbursement structure
    • 7.3.2.3. Competitive scenario
    • 7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.3.3. Mexico
    • 7.3.3.1. Key country dynamics
    • 7.3.3.2. Regulatory framework/ reimbursement structure
    • 7.3.3.3. Competitive scenario
    • 7.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
• 7.4. Europe
  • 7.4.1. UK
    • 7.4.1.1. Key country dynamics
    • 7.4.1.2. Regulatory framework/ reimbursement structure
    • 7.4.1.3. Competitive scenario
    • 7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.2. Germany
    • 7.4.2.1. Key country dynamics
    • 7.4.2.2. Regulatory framework/ reimbursement structure
    • 7.4.2.3. Competitive scenario
    • 7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.3. France
    • 7.4.3.1. Key country dynamics
    • 7.4.3.2. Regulatory framework/ reimbursement structure
    • 7.4.3.3. Competitive scenario
    • 7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.4. Italy
    • 7.4.4.1. Key country dynamics
    • 7.4.4.2. Regulatory framework/ reimbursement structure
    • 7.4.4.3. Competitive scenario
    • 7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.5. Spain
    • 7.4.5.1. Key country dynamics
    • 7.4.5.2. Regulatory framework/ reimbursement structure
    • 7.4.5.3. Competitive scenario
    • 7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.6. Norway
    • 7.4.6.1. Key country dynamics
    • 7.4.6.2. Regulatory framework/ reimbursement structure
    • 7.4.6.3. Competitive scenario
    • 7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.7. Sweden
    • 7.4.7.1. Key country dynamics
    • 7.4.7.2. Regulatory framework/ reimbursement structure
    • 7.4.7.3. Competitive scenario
    • 7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.8. Denmark
    • 7.4.8.1. Key country dynamics
    • 7.4.8.2. Regulatory framework/ reimbursement structure
    • 7.4.8.3. Competitive scenario
    • 7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Japan
    • 7.5.1.1. Key country dynamics
    • 7.5.1.2. Regulatory framework/ reimbursement structure
    • 7.5.1.3. Competitive scenario
    • 7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.2. China
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Regulatory framework/ reimbursement structure
    • 7.5.2.3. Competitive scenario
    • 7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.3. India
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Regulatory framework/ reimbursement structure
    • 7.5.3.3. Competitive scenario
    • 7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.4. Australia
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Regulatory framework/ reimbursement structure
    • 7.5.4.3. Competitive scenario
    • 7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.5. South Korea
    • 7.5.5.1. Key country dynamics
    • 7.5.5.2. Regulatory framework/ reimbursement structure
    • 7.5.5.3. Competitive scenario
    • 7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.6. Thailand
    • 7.5.6.1. Key country dynamics
    • 7.5.6.2. Regulatory framework/ reimbursement structure
    • 7.5.6.3. Competitive scenario
    • 7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 7.6. Latin America
  • 7.6.1. Brazil
    • 7.6.1.1. Key country dynamics
    • 7.6.1.2. Regulatory framework/ reimbursement structure
    • 7.6.1.3. Competitive scenario
    • 7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.2. Argentina
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Regulatory framework/ reimbursement structure
    • 7.6.2.3. Competitive scenario
    • 7.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 7.7. MEA
  • 7.7.1. South Africa
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Regulatory framework/ reimbursement structure
    • 7.7.1.3. Competitive scenario
    • 7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.2. Saudi Arabia
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Regulatory framework/ reimbursement structure
    • 7.7.2.3. Competitive scenario
    • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.3. UAE
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Regulatory framework/ reimbursement structure
    • 7.7.3.3. Competitive scenario
    • 7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.4. Kuwait
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Regulatory framework/ reimbursement structure
    • 7.7.4.3. Competitive scenario
    • 7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Company/Competition Categorization
• 8.2. Vendor Landscape
  • 8.2.1. List of key distributors and channel partners
  • 8.2.2. Key company market share analysis, 2023
  • 8.2.3. AstraZeneca PLC
    • 8.2.3.1. Company overview
    • 8.2.3.2. Financial performance
    • 8.2.3.3. Product benchmarking
    • 8.2.3.4. Strategic initiatives
  • 8.2.4. Boehringer Ingelheim International GmbH
    • 8.2.4.1. Company overview
    • 8.2.4.2. Financial performance
    • 8.2.4.3. Product benchmarking
    • 8.2.4.4. Strategic initiatives
  • 8.2.5. Eli Lilly and Co.
    • 8.2.5.1. Company overview
    • 8.2.5.2. Financial performance
    • 8.2.5.3. Product benchmarking
    • 8.2.5.4. Strategic initiatives
  • 8.2.6. Merck & Co. Inc
    • 8.2.6.1. Company overview
    • 8.2.6.2. Financial performance
    • 8.2.6.3. Product benchmarking
    • 8.2.6.4. Strategic initiatives
  • 8.2.7. Novartis AG
    • 8.2.7.1. Company overview
    • 8.2.7.2. Financial performance
    • 8.2.7.3. Product benchmarking
    • 8.2.7.4. Strategic initiatives
  • 8.2.8. Novo Nordisk AS
    • 8.2.8.1. Company overview
    • 8.2.8.2. Financial performance
    • 8.2.8.3. Product benchmarking
    • 8.2.8.4. Strategic initiatives
  • 8.2.9. Sanofi SA
    • 8.2.9.1. Company overview
    • 8.2.9.2. Financial performance
    • 8.2.9.3. Product benchmarking
    • 8.2.9.4. Strategic initiatives
  • 8.2.10. Takeda Pharmaceutical Co. Ltd
    • 8.2.10.1. Company overview
    • 8.2.10.2. Financial performance
    • 8.2.10.3. Product benchmarking
    • 8.2.10.4. Strategic initiatives